About Peter Fuhrken
Form D filings for RYNE Biotechnology in 2024 list Peter Fuhrken as director.
Peter Fuhrken first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Fuhrken in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Fuhrken works with at each company, as listed on that company's latest Form D.
RYNE Biotechnology Inc. · Form D, Mar 1, 2024
JG
Jeff Goater
Director
HF
Howard Federoff
Executive officer and director
NM
Nick Manusos
CEO and director
DF
David Fallace
Director
JJ
Jeff Jonas
Director
MO
Martin Ostrowski
Executive officer
JY
Jonathan Yeh
Director